BRUIN CLL-314: A phase III open-label, randomized study of pirtobrutinib (LOXO-305) versus ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma Meeting Abstract
| Authors: | Woyach, J. A.; Wierda, W. G.; Coombs, C. C.; Lewis, K. L.; Gribben, J. G.; Escalon, M. P.; Ceccarelli, M.; Wu, X.; Mato, A. R. |
| Abstract Title: | BRUIN CLL-314: A phase III open-label, randomized study of pirtobrutinib (LOXO-305) versus ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 12427 |
| End Page: | 12428 |
| Language: | English |
| ACCESSION: | WOS:000893230305221 |
| DOI: | 10.1182/blood-2022-157589 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
